期刊文献+

非酒精性脂肪性肝病无创诊断和评估的临床研究进展 被引量:7

Progress in Non-invasive Diagnosis and Assessment of Non-alcoholic Fatty Liver Disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是指除外长期大量饮酒和其他损伤肝脏因素所引起的以肝脏脂肪沉积为主要表现的临床综合征,其发病机制与环境、遗传、免疫等多种因素相关。早期诊断有助于鉴别单纯性非酒精性脂肪肝(NAFL)和非酒精性脂肪性肝炎(NASH),同时可对NAFLD病变程度进行分级并延缓其进一步发展。本文就NAFLD无创诊断和评估的临床研究进展作一综述。 Non-alcoholic fatty liver disease( NAFLD) is a clinical syndrome characterized by hepatic fat deposition,and not caused by chronic heavy drinking and other liver damage factors. The pathogenesis of NAFLD is associated with environmental,genetic,immune and other various factors. Early diagnosis is helpful not only for distinguishing between simple non-alcoholic fatty liver( NAFL) and non-alcoholic steatohepatitis( NASH),but also for grading the extent of NAFLD lesion and delaying its further development. This article reviewed the clinical research progress of non-invasive diagnosis and evaluation of NAFLD.
出处 《胃肠病学》 2017年第9期561-564,共4页 Chinese Journal of Gastroenterology
关键词 非酒精性脂肪性肝病 非酒精性脂肪性肝炎 肝硬化 生物学标记 无创诊断 Non-Alcoholic Fatty Liver Disease Non-Alcoholic Steatohepatitis Liver Cirrhosis Biological Markers Non-Invasive Diagnosis
  • 相关文献

参考文献2

二级参考文献54

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2王宇,贾继东.Fibroscan评价肝纤维化进程[J].肝脏,2007,12(5):336-338. 被引量:29
  • 3William Nseir,Julnar Mograbi,Murad Ghali.Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies[J]. Digestive Diseases and Sciences . 2012 (7)
  • 4European Association for the Study of the Liver,Ginès P,Angeli P,et al.EASL clinical practice guidelines on the man-agement of ascites,spontaneous bacterial peritonitis,and hepa-torenal syndrome in cirrhosis. Journal of Hepatology . 2010
  • 5D. Lebrec,J.P. Vinel,J.L. Dupas.Complications of portal hypertension in adults: a French consensus. European Journal of Gastroenterology and Hepatology . 2005
  • 6Adams LA,Lindor KD.Nonalcoholic fatty liver disease. Annals of Epidemiology . 2007
  • 7L.J. Melton.History of the Rochester Epidemiology Project. Mayo Clinic Proceedings . 1996
  • 8M Ekstedt,LE Franzén,UL Mathiesen,M Holmqvist,G Bodemar,S Kechagias.Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. Journal of Hepatology . 2007
  • 9A Uygun,A Kadayifci,AT Isik,T Ozgurtas,S Deveci,A Tuzun.Metformin in the treatment of patients with non-alcoholic steatohepatitis. Alimentary Pharmacology and Therapeutics . 2004
  • 10Ajamieh H,Farrell G,Wong HJ,et al.Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4suppression and endothelial nitric oxide synthase activation. Journal of Gastroenterology . 2012

共引文献20

同被引文献75

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部